Arbutus Biopharma (ABUS)
(Delayed Data from NSDQ)
$3.20 USD
-0.14 (-4.19%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $3.21 +0.01 (0.31%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.10 |
EPS Last Quarter | -0.10 |
Last EPS Surprise | 0.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.39 |
Next Year | -0.41 |
EPS (TTM) | -0.44 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.54M | 1.56M | 7.43M | 6.57M |
# of Estimates | 2 | 2 | 3 | 3 |
High Estimate | 1.58M | 1.62M | 9.80M | 7.80M |
Low Estimate | 1.50M | 1.50M | 6.10M | 5.80M |
Year ago Sales | 4.65M | 4.66M | 18.14M | 7.43M |
Year over Year Growth Est. | -66.88% | -66.52% | -59.04% | -11.63% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.10 | -0.10 | -0.39 | -0.41 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | -0.10 | -0.10 | -0.38 | -0.39 |
High Estimate | -0.10 | -0.10 | -0.36 | -0.39 |
Low Estimate | -0.10 | -0.10 | -0.41 | -0.43 |
Year ago EPS | -0.10 | -0.12 | -0.44 | -0.39 |
Year over Year Growth Est. | 0.00% | 16.67% | 11.36% | -6.84% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.10 | -0.10 | -0.39 | -0.41 |
7 Days Ago | -0.10 | -0.10 | -0.39 | -0.41 |
30 Days Ago | -0.10 | -0.10 | -0.39 | -0.41 |
60 Days Ago | -0.10 | -0.10 | -0.39 | -0.43 |
90 Days Ago | -0.10 | -0.10 | -0.39 | -0.43 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.10 | -0.10 | -0.39 | -0.41 |
Zacks Consensus Estimate | -0.10 | -0.10 | -0.39 | -0.41 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.10 | -0.12 | -0.12 | -0.10 | NA |
Estimate | -0.10 | -0.12 | -0.12 | -0.12 | NA |
Difference | 0.00 | 0.00 | 0.00 | 0.02 | 0.01 |
Surprise | 0.00% | 0.00% | 0.00% | 16.67% | 4.17% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more